Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Snider

Showing results (241-250 of 286) with videos related to

Pageof 29
Sort By:
Vaccine|September 5, 2021
Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trialKhalequ Zaman, Stephanie D Kovacs, Kristin Vanderende, et al.
The Lancet. Infectious Diseases|March 25, 2018
Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trialKhalequ Zaman, Concepción F Estívariz, Michelle Morales, et al.
Cell Death & Disease|March 4, 2016
Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune systemK Wang, R Xu, A J Snider, et al.
Journal of the American Society of Nephrology : JASN|October 2, 2014
Renal glycosphingolipid metabolism is dysfunctional in lupus nephritisTamara K Nowling, Andrew R Mather, Thirumagal Thiyagarajan, et al.
Prostaglandins & Other Lipid Mediators|August 25, 2023
A novel HSPB1<sup>S139F</sup> mouse model of Charcot-Marie-Tooth DiseaseKeila S Espinoza, Kyra N Hermanson, Cameron A Beard, et al.
Lancet (London, England)|May 21, 2019
Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trialCynthia J Snider, Khalequ Zaman, Concepcion F Estivariz, et al.
Cellular Signalling|December 8, 2020
Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. ObeidFabiola N Velazquez, Maria Hernandez-Corbacho, Magali Trayssac, et al.
The Journal of Biological Chemistry|February 22, 2011
Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidaseRussell W Jenkins, Christopher J Clarke, Daniel Canals, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Secretory acid sphingomyelinase activity is elevated in persons with colorectal neoplasiaJustin M Snider, Elise K Batzli, Madison L Hannan, et al.
Oncogene|December 14, 2023
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancerShailender S Chauhan, Andrea L Casillas, Andres D Vizzerra, et al.
Pageof 29

Showing results (241-250 of 286) with videos related to

Sort By:
Pageof 29
Vaccine|September 5, 2021
Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trialKhalequ Zaman, Stephanie D Kovacs, Kristin Vanderende, et al.
The Lancet. Infectious Diseases|March 25, 2018
Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trialKhalequ Zaman, Concepción F Estívariz, Michelle Morales, et al.
Cell Death & Disease|March 4, 2016
Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune systemK Wang, R Xu, A J Snider, et al.
Journal of the American Society of Nephrology : JASN|October 2, 2014
Renal glycosphingolipid metabolism is dysfunctional in lupus nephritisTamara K Nowling, Andrew R Mather, Thirumagal Thiyagarajan, et al.
Prostaglandins & Other Lipid Mediators|August 25, 2023
A novel HSPB1<sup>S139F</sup> mouse model of Charcot-Marie-Tooth DiseaseKeila S Espinoza, Kyra N Hermanson, Cameron A Beard, et al.
Lancet (London, England)|May 21, 2019
Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trialCynthia J Snider, Khalequ Zaman, Concepcion F Estivariz, et al.
Cellular Signalling|December 8, 2020
Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. ObeidFabiola N Velazquez, Maria Hernandez-Corbacho, Magali Trayssac, et al.
The Journal of Biological Chemistry|February 22, 2011
Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidaseRussell W Jenkins, Christopher J Clarke, Daniel Canals, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Secretory acid sphingomyelinase activity is elevated in persons with colorectal neoplasiaJustin M Snider, Elise K Batzli, Madison L Hannan, et al.
Oncogene|December 14, 2023
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancerShailender S Chauhan, Andrea L Casillas, Andres D Vizzerra, et al.
Pageof 29